HIG.TO
Brompton Global Healthcare Income & Growth ETF
Global
EQUITY
Active
MANAGEMENT STYLE
$ 64.2 M
ASSETS UNDER MGMT
75 bp
EXPENSES
Fund Basics
| Inception date | Sep 24, 2015 |
| Regulation | |
| Fund Website | link... |
| Distributions | |
| Currency | CAD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| JOHNSON & JOHNSON | 6.5 % |
| ELI LILLY & CO | 5.9 % |
| NOVARTIS AG-ADR | 5.5 % |
| GILEAD SCIENCES INC | 5.0 % |
| UNITEDHEALTH GROUP INC | 4.8 % |
| BRISTOL-MYERS SQUIBB CO | 4.7 % |
| CARDINAL HEALTH INC | 4.7 % |
| HCA HOLDINGS INC | 4.5 % |
| VERTEX PHARMACEUTICALS INC | 4.2 % |
| MCKESSON CORP | 4.1 % |
Constituent Breakdown
| Number of holdings | 27 |
| Herfindahl-Hirschman Index | 411 |
| Wgt avg mkt cap (mns) | $214,913 |
| Large cap (>$10bn) | 94.1% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 94.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 76.9 % |
 |
FRANCE | 5.7 % |
 |
SWITZERLAND | 5.5 % |
 |
BELGIUM | 3.1 % |
 |
BRITAIN | 3.0 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -10.2% | -5.1% | -8.9% | -4.7% | -6.2% | -2.0% | -- | -2.6% |
| Dividend Yield | 2.6% | 8.6% | 17.0% | 20.5% | 22.3% | 21.7% | -- | 21.1% |
| Total Returns | -7.6% | 3.5% | 8.2% | 15.8% | 16.1% | 19.7% | -- | 18.4% | Ann. Volatility | 14.1% | 13.8% | 17.0% | 17.3% | 19.0% | 20.6% | -- | 20.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.45 | 15% |
| MSCI EAFE | 0.44 | 24% |
| MSCI Emg Mkts | 0.21 | 10% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $7.19 |
| Relative strength (RSI) | 43 |
| MACD/Signal | -0.04/-0.06 |
| Bollinger Bands (Upper/Lower) | $7.24/$6.95 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HIG.TO |
Expenses vs. HIG.TO |
ALTAR Score™ vs. HIG.TO |
|---|---|---|---|---|
| LMAX.TO | Hamilton Healthcare YIELD MAXIMIZER TM ETF | 60.3% | -10 bp | +0.2% |
| HHL.TO | Harvest Healthcare Leaders Income ETF | 59.2% | +10 bp | -0.3% |
| MHCD.TO | Middlefield Healthcare Dividend ETF | 48.9% | +10 bp | -1.5% |
| MEDX.TO | Global X Equal Weight Global Healthcare Index ETF | 48.1% | -35 bp | +0.7% |
| TDOC.TO | TD Global Healthcare Leaders Index ETF | 39.3% | -40 bp | +0.2% |
| ZUH.TO | BMO Equal Weight US Health Care Hedged to CAD Index ETF | 24.3% | -40 bp | -1.3% |
| ZHU.TO | BMO Equal Weight US Health Care Index ETF | 23.7% | -40 bp | -1.6% |
| FHH.TO | First Trust AlphaDEX U.S. Health Care Sector Index ETF | 19.0% | +1 bp | +0.8% |
| KNGU.TO | Brompton U.S. Cash Flow Kings ETF | 13.8% | -30 bp | +2.9% |
| XEXP.TO | iShares Exponential Technologies Index ETF | 13.6% | -36 bp | -2.8% |
Risk and Returns: HIG.TO vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (CAD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/18/2026
Peer Group Comparison
Sample data. Subscribe for access.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.1%
ALTAR SCORE™
85th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 731 funds in the Global Equity category with an average
ALTAR Score™ of 4.3% and a standard deviation
of 2.6%. HIG.TO's ALTAR Score™ is approximately 1.1 standard
deviations above the category average. This places HIG.TO in the 85th percentile
among funds in the category.
Sell-Side Consensus
$8.59
PRICE TARGET
+21.0%
UPSIDE